Firm News

Home 9 News Item 9 Biovitrum AB and Amgen Inc. sign important agreement for the development and marketing of drugs for diabetes and other metabolic disorders, assisted by Wiggin & Dana’s Biotechnology & Life Sciences Practice Group.

Biovitrum AB and Amgen Inc. sign important agreement for the development and marketing of drugs for diabetes and other metabolic disorders, assisted by Wiggin & Dana’s Biotechnology & Life Sciences Practice Group.

September 9, 2003

Amgen Inc. (NASDAQ: AMGN) and Biovitrum AB today announced that they have signed a multifaceted agreement under which Amgen receives exclusive rights to develop and commercialize Biovitrum’s small molecule 11betaHSD1 enzyme inhibitors for the treatment of metabolic diseases and certain other medical disorders.

Amgen Biovitrum deal-announce.pdf

Resources

Firm Highlights

Recognized for Excellence: Wiggin and Dana Named Law Firm of the Year, Attorney of the Year, and Earns 8 Additional Honors at the 2025 New England Legal Awards

Wiggin and Dana is proud to announce an extraordinary achievement at The American Lawyer’s 2025 New England Legal Awards, where the firm earned 10 top honors and was recognized as a finalist in additional categories. These awards celebrate excellence across the legal profession, and this year’s results underscore Wiggin and Dana’s commitment to delivering exceptional […]

Wiggin and Dana Celebrates Top Honors in Benchmark Litigation’s 2026 Rankings

Wiggin and Dana is proud to announce that Benchmark Litigation has once again recognized the firm’s excellence in litigation, naming 13 attorneys as “Litigation Stars” and three attorneys as “Future Stars” in its 2026 edition. The firm also earned Benchmark’s highest distinction, being ranked as a “Highly Recommended” firm. Benchmark Litigation praised Wiggin and Dana […]

The National Law Journal Shortlists Wiggin and Dana for Litigation Departments of the Year – White Collar

Wiggin and Dana is proud to announce that its White Collar Defense, Investigations, and Corporate Compliance Practice Group has been selected by The National Law Journal as a finalist for Litigation Departments of the Year, White Collar. The firm’s White Collar Defense, Investigations, and Corporate Compliance Practice Group includes former federal prosecutors from the U.S. […]

Benchmark Litigation Names Wiggin and Dana Partners to the 2025 “40 & Under List”

Wiggin and Dana Litigation Partners, Laura Ann K. Froning, Robyn E. Gallagher, and David Norman-Schiff were named to Benchmark Litigation’s 2025 “40 & Under List”. The Benchmark Litigation team bestows this distinction upon the nation’s most accomplished litigators aged 40 and younger who are considered the top emerging talent in litigation. The list is compiled based […]

Wiggin and Dana Expands Real Estate Practice with Addition of Vasiliki Yiannoulis-Riva

Wiggin and Dana LLP is pleased to announce that Vasiliki (Vasi) Yiannoulis-Riva has joined the firm as a Partner in the Real Estate, Environmental, Construction and Facilities Department, based in both the Stamford, CT and New York, NY offices. Vasi brings more than a decade of experience advising clients on commercial real estate transactions, leasing, […]

Chambers High Net Worth 2025 Honors Wiggin and Dana Lawyers and Private Client Services Practice

Wiggin and Dana is pleased to announce that the firm’s Private Client Services practice and its partners, Michael T. Clear, Daniel L. Daniels, Jevera K. Hennessey, Leonard Leader, Vanessa L. Maczko, Steven B. Malech, and Carolyn A. Reers, have been ranked in the ninth edition of the annual Chambers High Net Worth (HNW) 2025 Guide. Additionally, Jonathan […]